Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Inge Johnsen

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Frontiers in Oncology|February 15, 2021
MYCN Function in Neuroblastoma DevelopmentJörg Otte, Cecilia Dyberg, Adena Pepich, et al.
Cell Cycle (Georgetown, Tex.)|June 29, 2010
Medulloblastoma: a disease with disorganized developmental signaling cascadesNinib Baryawno, Baldur Sveinbjörnsson, Per Kogner, et al.
Plos One|April 25, 2014
Sunitinib suppress neuroblastoma growth through degradation of MYCN and inhibition of angiogenesisRaul Calero, Esther Morchon, John Inge Johnsen, et al.
Cancers|May 25, 2024
The Neuroblastoma Microenvironment, Heterogeneity and Immunotherapeutic ApproachesPanagiotis Alkinoos Polychronopoulos, Oscar C Bedoya-Reina, John Inge Johnsen
Apoptosis : an International Journal on Programmed Cell Death|March 5, 2009
Embryonal neural tumours and cell deathJohn Inge Johnsen, Per Kogner, Ami Albihn, et al.
International Journal of Cancer|February 14, 2003
The synthetic retinoid RO 13-6307 induces neuroblastoma differentiation in vitro and inhibits neuroblastoma tumour growth in vivoFrida Ponthan, John Inge Johnsen, Lena Klevenvall, et al.
International Journal of Cancer|December 15, 2005
Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stressMagnus Lindskog, Helena Gleissman, Frida Ponthan, et al.
BMC Cancer|July 20, 2016
The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesisIgor Snapkov, Carl Otto Öqvist, Yngve Figenschau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous NeuroblastomaYumeng Mao, Nina Eissler, Katarina Le Blanc, et al.
Cancer Research|December 24, 2009
Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growthNinib Baryawno, Baldur Sveinbjörnsson, Staffan Eksborg, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|February 15, 2021
MYCN Function in Neuroblastoma DevelopmentJörg Otte, Cecilia Dyberg, Adena Pepich, et al.
Cell Cycle (Georgetown, Tex.)|June 29, 2010
Medulloblastoma: a disease with disorganized developmental signaling cascadesNinib Baryawno, Baldur Sveinbjörnsson, Per Kogner, et al.
Plos One|April 25, 2014
Sunitinib suppress neuroblastoma growth through degradation of MYCN and inhibition of angiogenesisRaul Calero, Esther Morchon, John Inge Johnsen, et al.
Cancers|May 25, 2024
The Neuroblastoma Microenvironment, Heterogeneity and Immunotherapeutic ApproachesPanagiotis Alkinoos Polychronopoulos, Oscar C Bedoya-Reina, John Inge Johnsen
Apoptosis : an International Journal on Programmed Cell Death|March 5, 2009
Embryonal neural tumours and cell deathJohn Inge Johnsen, Per Kogner, Ami Albihn, et al.
International Journal of Cancer|February 14, 2003
The synthetic retinoid RO 13-6307 induces neuroblastoma differentiation in vitro and inhibits neuroblastoma tumour growth in vivoFrida Ponthan, John Inge Johnsen, Lena Klevenvall, et al.
International Journal of Cancer|December 15, 2005
Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stressMagnus Lindskog, Helena Gleissman, Frida Ponthan, et al.
BMC Cancer|July 20, 2016
The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesisIgor Snapkov, Carl Otto Öqvist, Yngve Figenschau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous NeuroblastomaYumeng Mao, Nina Eissler, Katarina Le Blanc, et al.
Cancer Research|December 24, 2009
Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growthNinib Baryawno, Baldur Sveinbjörnsson, Staffan Eksborg, et al.
Pageof 9